KFDA approves two homegrown drugs

Published: 2011-08-22 06:58:00

Updated: 2011-08-22 06:58:00

Demonstrating the strength of the country's R&D capabilities, the Korea Food and Drug Administration Wednesday approved two Korean drugs – Shinpoong Pharmaceutical’s anti-malarial drug ‘Pyramax’ and JW Pharmaceutical’s Zepid (avanafil) for treatment of erectile dysfunction (ED).

Thus Korea bec...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK